European Journal of Nuclear Medicine and Molecular Imaging
译名:欧洲核医学与分子影像学杂志
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
5-10
2026
影响因子区间
87天
平台估算
36%
2025
中国作者发文占比
1800 EUR
收费
期刊简介:The aim of the European Journal of Nuclear Medicine and Molecular Imaging is to provide a forum for the exchange of clinical and scientific information for the imaging community and allied professions involved in the functional, metabolic and molecular investigation of diseases. The European Journal of Nuclear Medicine and Molecular Imaging will remain of primary interest to those practicing the field of imaging, radiopharmaceutical therapy and image guided therapy. The field of interest includes advanced imaging analyses techniques and artificial intelligence application in the field of imaging. Reports on original works related to physics, dosimetry, radiation biology, radiochemistry and pharmacy, will be considered in the field of interest of the EJNMMI. The Journal will welcome original material reflecting the field of molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression and antisense methodologies.The Journal will continue to publish in depth Reviews of topical interest, Short communications, Controversies, interesting images and Letters to the editor. Case reports are not published.The journal publishes the following article types:Original article,Review article,Letter to the Editor,Guidelines,Controversies,Image of the month,Short Communications,Editorials
【译文】欧洲核医学与分子影像学杂志旨在为影像学社区及其在疾病功能、代谢和分子调查中涉及的相关专业提供交流临床和科学信息的平台。该杂志对从事影像学、放射性药物疗法和影像引导疗法领域的实践者具有首要意义。感兴趣领域包括先进的影像分析技术和影像领域的人工智能应用。有关物理学、剂量学、辐射生物学、放射化学和药学的原创作品将被考虑在EJNMMI的兴趣领域内。该杂志将欢迎反映分子影像探针、报告基因检测、细胞运输、内源性基因表达靶向和反义方法领域的原创材料。该杂志将继续发表有关热门话题的深入评论、简报、争议、有趣图像和编辑信函。不发表病例报告。该杂志出版以下文章类型:原创文章、评论文章、编辑信函、指南、争议、本月影像、简报、社论。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q1 | 暂无 |
| 影响因子区间 | 5-10 | 暂无 |